HEOR服務市場規模、佔有率和成長分析：按服務類型、服務供應商、部署模式、應用、最終用戶、研究類型和地區分類－2026-2033年產業預測

2024 年全球 HEOR 服務市值為 21 億美元，預計到 2025 年將成長至 23.6 億美元，到 2033 年將成長至 59.1 億美元，在預測期（2026-2033 年）內複合年成長率為 12.19%。

隨著相關人員對臨床療效、成本效益和患者報告結局 (PRO) 的可靠證據需求日益成長，全球衛生經濟學與結果研究 (HEOR) 服務市場預計將迎來顯著成長。這一趨勢源於在醫療預算日益緊縮和處方藥價格不斷上漲的背景下，企業需要證明產品價值。該市場已從早期的藥物經濟學研究發展到如今成熟的 HEOR 項目，並利用真實世界數據 (RWE) 和預測分析，以及電子健康記錄 (EHR) 和保險理賠資料庫等廣泛的數據存儲庫。這些進步使製藥公司能夠將自身產品與競爭對手的臨床療效進行比較和評估，並預測上市後的安全性和預算影響。真實世界數據的激增正在擴大基於結果的合約和處方藥清單的適用範圍，例如在糖尿病等治療領域成功證明其價值，最終推動患者照護和業務策略的改進。

全球健康經濟學與結果研究（HEOR）服務市場促進因素

對醫療結果與經濟研究 (HEOR) 服務日益成長的需求，正促使醫療利益相關人員尋求能夠提供針對不同患者群體、治療方法和長期影響的可操作性見解的深度分析。保險公司和醫療服務提供者越來越需要比較療效和價值的證據，以指南保險覆蓋範圍決策和臨床實踐，這需要專業的建模和數據解讀能力。製藥公司正努力向不同的相關人員突顯產品的差異化和價值，從而增加了對 HEOR 能力的投資。反過來，這又推動了 HEOR 服務的更廣泛應用，並鼓勵醫療服務提供者改進調查方法和諮詢活動。

全球衛生經濟學與結果研究（HEOR）服務市場的限制因素

全球衛生經濟學與結果研究（HEOR）服務市場面臨許多限制因素，包括資料集碎片化、編碼規範不一致以及結果指標差異。這些挑戰導致調查方法複雜化，使得HEOR研究的設計與解讀更加困難且充滿不確定性。資料來源之間缺乏可靠的協調統一，可能導致服務供應商難以產生清晰且具有普遍適用性的證據，從而削弱客戶信心並阻礙採購決策。整合多樣化的輸入資料需要額外的時間和專業知識，這增加了專案成本和資源需求。這可能會阻礙相關人員利用全面的HEOR服務，最終限制服務提供者在不同醫療保健系統中擴展服務的能力。

全球健康經濟學與結果研究（HEOR）服務市場趨勢

全球健康經濟學與結果研究 (HEOR) 服務市場正經歷著顯著的轉變，即更加重視將真實世界證據 (RWE) 融入有效的衛生經濟學和結果研究策略的發展中。這一趨勢強調利用各種數據來源，例如觀察性研究、保險理賠數據和患者報告結果 (PRO)，以在整個產品生命週期中建立全面的價值主張和合理的定價模型。 HEOR 團隊正擴大採用創新方法來分析複雜的資料集，從而支持基於日常醫療保健的知情決策和長期結果評估。資料科學家、臨床醫生和市場進入負責人之間加強的跨職能協作正在簡化證據生成流程，促進價值溝通，並推動衛生經濟學模型的演進，從而提高效率和效果。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球健康經濟學與結果研究（HEOR）服務市場規模：按服務類型分類

• 健康經濟服務
  • 成本效益分析
  • 預算影響分析
  • 成本效益分析
  • 其他
• 結果研究服務
  • 患者報告結局調查
  • 比較效果研究
  • 真實世界證據研究
  • 其他
• 市場進入服務
  • 定價和還款支持
  • HTA應用支援
  • 價值檔案創建
• 數據分析和建模服務
• 其他

全球衛生經濟學和結果研究（HEOR）服務市場規模：按服務供應商分類

• 受託研究機構
• 顧問公司
• 醫療保健分析公司
• 其他

全球健康經濟學與結果研究（HEOR）服務市場規模：依部署類型分類

• 內部服務
• 外包服務

全球健康經濟學與結果研究（HEOR）服務市場規模：按應用領域分類

• 腫瘤學
• 心血管疾病
• 神經病學
• 感染疾病
• 罕見疾病
• 代謝性疾病
• 其他

全球健康經濟學與結果研究（HEOR）服務市場規模：依最終用戶分類

• 製藥公司
• 生技公司
• 醫療設備製造商
• 醫療服務提供方
• 政府和保險公司
• 其他

全球健康經濟學和結果研究（HEOR）服務市場規模：按調查類型分類

• 回顧性研究
• 前瞻性研究
• 基於模型的研究

全球健康經濟學與結果研究（HEOR）服務市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• IQVIA Holdings Inc.
• Parexel International Corporation
• Syneos Health Inc.
• ICON plc
• EVERSANA
• Certara Inc.
• Optum Inc.
• Analysis Group Inc.
• RTI Health Solutions
• Clarivate Plc
• Pharmerit International
• Precision AQ
• Trinity Life Sciences
• Avalere Health LLC
• ZS Associates Inc.
• Kx Advisors LLC
• Putnam Associates Inc.
• McKesson Corporation
• Cytel Inc.
• Oracle Life Sciences

結論與建議

Global Heor Services Market size was valued at USD 2.1 Billion in 2024 and is poised to grow from USD 2.36 Billion in 2025 to USD 5.91 Billion by 2033, growing at a CAGR of 12.19% during the forecast period (2026-2033).

The global HEOR Services market is poised for significant growth as stakeholders increasingly demand robust evidence illustrating clinical effectiveness, cost-effectiveness, and patient-reported outcomes. This trend arises from the need to justify product value amidst tightening healthcare budgets and rising prescription drug prices. Evolving from early pharmacoeconomic studies to sophisticated HEOR programs, the market now leverages real-world evidence and predictive analytics supported by extensive data repositories like Electronic Health Records and claims databases. This advancement allows manufacturers to assess clinical efficacy against competitors and predict post-launch safety and budget implications. The proliferation of real-world data enhances opportunities for outcomes-based contracting and formulary access, exemplified by successful value demonstrations in therapeutic areas like diabetes, ultimately fostering improved patient care and business strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Heor Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Heor Services Market Segments Analysis

Global heor services market is segmented by by service type, by service provider, by deployment type, by application, by end user, by study type and region. Based on by service type, the market is segmented into Health Economics Services, Outcomes Research Services, Market Access Services, Data Analytics & Modeling Services and Others. Based on by service provider, the market is segmented into Contract Research Organizations, Consulting Firms, Healthcare Analytics Companies and Others. Based on by deployment type, the market is segmented into In-house Services and Outsourced Services. Based on by application, the market is segmented into Oncology, Cardiovascular Disorders, Neurology, Infectious Diseases, Rare Diseases, Metabolic Disorders and Others. Based on by end user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Healthcare Providers, Government & Payers and Others. Based on by study type, the market is segmented into Retrospective Studies, Prospective Studies and Modeling-based Studies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Heor Services Market

The growing demand for healthcare outcomes and economic research (HEOR) services is driving healthcare stakeholders to pursue in-depth analyses that yield actionable insights across various patient demographics, treatment methods, and long-term effects. Payers and providers increasingly seek evidence of comparative effectiveness and value to guide coverage decisions and clinical practices, which necessitates specialized modeling and data interpretation. Manufacturers strive to highlight product differentiation and value for an array of stakeholders, leading to increased investment in HEOR capabilities. This, in turn, is stimulating wider adoption of services and encouraging providers to enhance their methodological frameworks and consulting interactions.

Restraints in the Global Heor Services Market

The Global HEOR Services market faces significant restraints due to the fragmentation of datasets, inconsistent coding practices, and varying outcome measures. These challenges contribute to methodological complexities, making the design and interpretation of HEOR studies more arduous and uncertain. When data sources lack reliable harmonization, service providers struggle to generate clear and generalizable evidence, potentially diminishing client confidence and hindering procurement decisions. The need for additional time and expertise to reconcile diverse inputs escalates project costs and resource demands, which may deter stakeholders from utilizing extensive HEOR services, ultimately limiting providers' ability to expand their offerings across different healthcare systems.

Market Trends of the Global Heor Services Market

The Global HEOR Services market is witnessing a significant shift towards the integration of Real World Evidence (RWE) in shaping effective health economics and outcomes research strategies. This trend emphasizes leveraging diverse data sources such as observational studies, claims data, and patient-reported outcomes to create comprehensive value narratives and informed pricing models throughout product lifecycles. HEOR teams increasingly adopt innovative methodologies to analyze complex data sets, enabling informed decision-making and long-term outcome assessments from routine care. Enhanced cross-functional collaboration among data scientists, clinicians, and market access professionals is streamlining the evidence generation process, facilitating improved value communication, and evolving health economic models for greater efficiency and effectiveness.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global HEOR Services Market Size by Service Type & CAGR (2026-2033)

• Market Overview
• Health Economics Services
  • Cost-effectiveness Analysis
  • Budget Impact Analysis
  • Cost-benefit Analysis
  • Others
• Outcomes Research Services
  • Patient-reported Outcomes Research
  • Comparative Effectiveness Research
  • Real-world Evidence Studies
  • Others
• Market Access Services
  • Pricing & Reimbursement Support
  • HTA Submission Support
  • Value Dossier Development
• Data Analytics & Modeling Services
• Others

Global HEOR Services Market Size by Service Provider & CAGR (2026-2033)

• Market Overview
• Contract Research Organizations
• Consulting Firms
• Healthcare Analytics Companies
• Others

Global HEOR Services Market Size by Deployment Type & CAGR (2026-2033)

• Market Overview
• In-house Services
• Outsourced Services

Global HEOR Services Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncology
• Cardiovascular Disorders
• Neurology
• Infectious Diseases
• Rare Diseases
• Metabolic Disorders
• Others

Global HEOR Services Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Companies
• Healthcare Providers
• Government & Payers
• Others

Global HEOR Services Market Size by Study Type & CAGR (2026-2033)

• Market Overview
• Retrospective Studies
• Prospective Studies
• Modeling-based Studies

Global HEOR Services Market Size & CAGR (2026-2033)

• North America (By Service Type, By Service Provider, By Deployment Type, By Application, By End User, By Study Type)
  • US
  • Canada
• Europe (By Service Type, By Service Provider, By Deployment Type, By Application, By End User, By Study Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (By Service Type, By Service Provider, By Deployment Type, By Application, By End User, By Study Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (By Service Type, By Service Provider, By Deployment Type, By Application, By End User, By Study Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (By Service Type, By Service Provider, By Deployment Type, By Application, By End User, By Study Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IQVIA Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EVERSANA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Certara Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optum Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Analysis Group Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RTI Health Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clarivate Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmerit International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision AQ
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avalere Health LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZS Associates Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kx Advisors LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Putnam Associates Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytel Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations